Aim & Scope

The OPENPUB Journal of Cancer Research & Reviews is dedicated to advancing the field of cancer research by publishing high-quality original research articles, reviews, and clinical case studies related to cancer treatment, diagnosis, and prevention. The journal serves as a global platform for the exchange of knowledge and ideas, aiming to accelerate the development of innovative therapies and clinical solutions.

Our goal is to publish groundbreaking research that addresses both basic and applied aspects of cancer biology, oncology, and related fields. The journal covers a broad range of topics, with a focus on the following areas:

  • Molecular Oncology: Research into cancer at the molecular level, including studies on cancer genes, mutations, and molecular mechanisms that contribute to cancer progression.
  • Immuno-oncology: Advancements in immunotherapy, including personalized cancer vaccines, checkpoint inhibitors, and CAR-T cell therapies.
  • Genetics and Cancer: Understanding the genetic underpinnings of cancer, hereditary factors, and the role of genetic mutations in cancer development.
  • Diagnostic Innovations: Breakthroughs in diagnostic techniques such as biomarkers, imaging methods, and early cancer detection technologies.
  • Therapeutics: Advances in chemotherapy, radiotherapy, and targeted therapy approaches, including clinical trials and therapeutic protocols.
  • Cancer Prevention: Public health strategies, early detection programs, and lifestyle modifications to reduce cancer risk.
  • Palliative Care: Research on enhancing the quality of life for cancer patients, including pain management, mental health, and post-treatment care.

By promoting interdisciplinary research and knowledge exchange, the journal aims to contribute to the global efforts to reduce the burden of cancer. Through timely publication and open access, we facilitate the rapid dissemination of research findings, which will ultimately translate into better clinical practices, improved treatments, and enhanced survival rates for cancer patients worldwide.